Biochemistry and Biophysics Reports

NOV 4, 2026 · JOURNAL ARTICLE

Phototoxic effects of pheophorbide-a nanoconjugates on melanoma tumor spheroids

Biochemistry and Biophysics Reports

Melanoma is the deadliest form of skin cancer, with a rapidly rising incidence and a poor prognosis for patients diagnosed at advanced stages. Photodynamic therapy (PDT) represents

OCT 24, 2026 · JOURNAL ARTICLE

Black Myrobalan (Terminalia chebula) as a potential multitarget neuroprotective agent: Translational insights and future directions in neurodegenerative diseases.

Biochemistry and Biophysics Reports

Myrobalan or Haritaki (Terminalia chebula Retz.) has been integrated into Ayurvedic, Unani, and even Tibetan medicine systems for over 2000 years. The "King of Medicines" has tradi

OCT 18, 2026 · JOURNAL ARTICLE

Bacterial competence and genetic diversity: Implications for the design of diagnostics and vaccines.

Biochemistry and Biophysics Reports

Bacterial competence and genetic diversity are key determinants of microbial evolution, directly influencing pathogen adaptability, diagnostic reliability, and vaccine effectivenes

OCT 9, 2026 · JOURNAL ARTICLE

Targeting ferroptosis in cancer: molecular mechanisms and emerging therapeutic strategies

Biochemistry and Biophysics Reports

Ferroptosis, an iron-dependent form of regulated cell death characterized by the lethal accumulation of lipid peroxides, has emerged as a pivotal pathway in cancer biology and a pr

OCT 2, 2026 · JOURNAL ARTICLE

Phospholipase A2 enhances the cytotoxic activity of membranolytic peptide Polybia MP1 in some breast epithelial cells

Biochemistry and Biophysics Reports

MP1, a peptide from the venom of the wasp Polybia paulista, has been investigated for anti-microbial and anti-cancer properties. The peptide binds and disrupts external-facing lipi

OCT 1, 2026 · JOURNAL ARTICLE

Engineered exosomes for breast cancer immunotherapy: Emerging strategies and translational potential

Biochemistry and Biophysics Reports

Breast cancer remains one of the leading causes of cancer-related mortality in women worldwide, despite significant advances in early detection and conventional therapies. Immunoth

SEP 25, 2026 · JOURNAL ARTICLE

Membrane-associated HDAC11: A potential new therapeutic targeting compartment in cancer cells

Biochemistry and Biophysics Reports

Histone deacetylase 11 (HDAC11), the sole member of class IV histone deacetylases, has emerged as a novel and promising therapeutic target in cancer owing to its unique structural

SEP 23, 2026 · JOURNAL ARTICLE

Preclinical evaluation of SLC35D3-targeted CAR-T cells for tumor-selective immunotherapy.

Biochemistry and Biophysics Reports

Chimeric antigen receptor (CAR)-T therapy has transformed management of hematological malignancies, yet efficacy in solid tumors is limited by scarcity of tumor-restricted antigens